Nano-Scale Drug Delivery For Chemotherapy

Oct 31, 2009 By Richard Merritt
Mouse tumor cells stain red, showing penetration of anti-cancer drug after 24 hours. Pratt School of Engineering

(PhysOrg.com) -- Going smaller could bring better results, especially when it comes to cancer-fighting drugs.

Duke University bioengineers have developed a simple and inexpensive method for loading cancer drug payloads into nano-scale delivery vehicles and demonstrated in animal models that this new nanoformulation can eliminate tumors after a single treatment. After delivering the drug to the tumor, the delivery vehicle breaks down into harmless byproducts, markedly decreasing the toxicity for the recipient.

Nano-delivery systems have become increasingly attractive to researchers because of their ability to efficiently get into tumors. Since supplying tumors are more porous, or leaky, than normal vessels, the nanoformulation can more easily enter and accumulate within . This means that higher doses of the drug can be delivered, increasing its cancer-killing abilities while decreasing the side effects associated with systematic chemotherapy

“When used to deliver anti-cancer medications in our models, the new formulation has a four-fold higher maximum tolerated dose than the same drug by itself, and it induced nearly complete after one injection,” said Ashutosh Chilkoti, Theo Pilkington Professor of Biomedical Engineering at Duke’s Pratt School of Engineering. “The free drug had only a modest effect in shrinking tumors or in prolonging animal survival”.

The results of Chilkoti’s experiments were published early online in the journal .

“Just as importantly, we believe, is the novel method we developed to create these drugs,” Chilkoti said. “Unlike other approaches, we can produce large quantities simply and inexpensively, and we believe the new method theoretically could be used to improve the effectiveness of other existing .”

Central to the new method is how the drug is “attached” to its polypeptide delivery system and whether or not a drug can be dissolved in water.

The makes use of the bacterium Escherichia coli (E. coli) which has been genetically altered to produce a specific artificial polypeptide known as a chimeric polypeptide. Since E. coli are commonly used to produce proteins, it makes for a simple and reliable production plant for these specific polypeptides with high yield.

When attached to one of these chimeric polypeptides, the drug takes on characteristics that the drug alone does not possess. Most drugs do not dissolve in water, which limits their ability to be taken in by cells. But being attached to a nanoparticle makes the drug soluble.

“When these two elements are combined in a container, they spontaneously self-assemble into a water-soluble nanoparticle,” Chilkoti said. “They also self-assemble consistently and reliably in a size of 50 nanometers or so that makes them ideal for cancer therapy. Since many chemotherapeutic drugs are insoluble, we believe that this new approach could work for them as well.”

The latest experiments involved doxorubicin, a commonly used agent for the treatment of cancers of the blood, breast, ovaries and other organs. The researchers injected mice with tumors implanted under their skin with either the chimeric polypeptide-doxorubicin combination or doxorubicin alone.

The mice treated with doxorubicin alone had an average tumor size 25 times greater than those treated with the new combination. The average survival time for the doxorubicin-treated mice was 27 days, compared to more than 66 days for mice getting the new formulation.

The Duke researchers now plan to test the new combination on different types of cancer, as well as tumors growing within different organs. They will also try combining these chimeric polypeptides with other insoluble drugs and test their effectiveness against tumors.

Provided by Duke University (news : web)

Explore further: Gelatin nanoparticles could deliver drugs to the brain

add to favorites email to friend print save as pdf

Related Stories

Weighting cancer drugs to make them hit tumors harder

Mar 02, 2006

Scientists have devised a blueprint for boosting anti-cancer drugs' effectiveness and lowering their toxicity by attaching the equivalent of a lead sinker onto the drugs. This extra weight makes the drugs penetrate and accumulate ...

Single-Dose Drug-Loaded Dendrimer Cures Mice of Colon Cancer

Nov 13, 2006

In a dramatic demonstration of the power of nanotechnology, a team of investigators has designed a nanoscale, polymeric drug delivery vehicle that when loaded with a widely used anticancer agent cures colon cancer in mice ...

Recommended for you

'Mind the gap' between atomically thin materials

Dec 24, 2014

When it comes to engineering single-layer atomic structures, "minding the gap" will help researchers create artificial electronic materials one atomic layer at a time, according to a team of materials scientists. ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

JackRJohnson
not rated yet Nov 02, 2009
Very interesting, not on AOP for Nature Materials yet, is this forthcoming?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.